|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 209.32 INR | -4.17% |
|
-17.62% | -15.46% |
| Capitalization | 3.42TCr 37Cr 32Cr 30Cr 28Cr 52Cr 55Cr 337.41Cr 133.7Cr 1.62TCr 140.2Cr 137.33Cr 5.92TCr | P/E ratio 2024 |
-24.1x | P/E ratio 2025 | 1,054x |
|---|---|---|---|---|---|
| Enterprise value | 5.3TCr 58Cr 49Cr 46Cr 43Cr 80Cr 85Cr 522.19Cr 206.92Cr 2.5TCr 216.98Cr 212.54Cr 9.16TCr | EV / Sales 2024 |
2.13x | EV / Sales 2025 | 1.95x |
| Free-Float |
29.66% | Yield 2024 * |
-
| Yield 2025 | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Dishman Carbogen Amcis Limited
| 1 day | -4.17% | ||
| 1 week | -17.62% | ||
| Current month | -15.46% | ||
| 1 month | -18.13% | ||
| 3 months | -26.66% | ||
| 6 months | -19.83% | ||
| Current year | -15.46% |
| 1 week | 205.4 |  | 254.41 |
| 1 month | 205.4 | | 267 |
| Current year | 205.4 | | 267 |
| 1 year | 178 | | 321.95 |
| 3 years | 80 | | 321.95 |
| 5 years | 80 | | 321.95 |
| 10 years | 46.05 | | 396.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 40 | 07/02/2019 | |
Harshil R. Dalal
DFI | Director of Finance/CFO | 44 | 28/11/2018 |
Paolo Armanino
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 75 | 17/03/2017 | |
| Director/Board Member | 40 | 17/03/2017 | |
| Director/Board Member | - | 01/04/2025 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.17% | -17.62% | -11.36% | +144.10% | 37Cr | |
| +0.82% | +5.27% | +44.22% | +214.21% | 97TCr | |
| +0.22% | -0.49% | +50.40% | +29.48% | 53TCr | |
| +0.91% | +0.63% | +28.91% | +45.81% | 39TCr | |
| -0.16% | -0.29% | +26.71% | +17.68% | 38TCr | |
| +0.58% | -2.90% | +23.52% | +23.61% | 28TCr | |
| +0.53% | +0.05% | +28.14% | +35.39% | 28TCr | |
| +2.38% | +4.28% | -30.20% | -15.99% | 28TCr | |
| -1.74% | -1.61% | +14.11% | -0.69% | 27TCr | |
| +1.01% | +5.16% | +26.93% | +31.85% | 19TCr | |
| Average | -0.10% | +0.14% | +20.14% | +52.54% | 35.6TCr | |
| Weighted average by Cap. | +0.17% | +2.10% | +29.72% | +74.82% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.62TCr 29Cr 24Cr 23Cr 21Cr 39Cr 42Cr 257.73Cr 102.13Cr 1.24TCr 107.09Cr 104.9Cr 4.52TCr | 2.71TCr 30Cr 25Cr 23Cr 22Cr 41Cr 43Cr 267.16Cr 105.87Cr 1.28TCr 111.01Cr 108.74Cr 4.69TCr |
| Net income | -153.45Cr -1.68Cr -1.43Cr -1.32Cr -1.24Cr -2.31Cr -2.45Cr -15Cr -5.99Cr -72Cr -6.28Cr -6.15Cr -265.25Cr | 3.24Cr 4L 3L 3L 3L 5L 5L 31.92L 12.65L 1.53Cr 13.26L 12.99L 5.6Cr |
| Net Debt | 1.88TCr 21Cr 17Cr 16Cr 15Cr 28Cr 30Cr 185.36Cr 73Cr 888.64Cr 77Cr 75Cr 3.25TCr | 1.88TCr 20Cr 17Cr 16Cr 15Cr 28Cr 30Cr 184.78Cr 73Cr 885.87Cr 77Cr 75Cr 3.24TCr |
More financial data
* Estimated data
Employees
1,106
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | 209.32 ₹ | -4.17% | 1,94,327 |
| 22/26/22 | 218.42 ₹ | +0.28% | 2,02,167 |
| 21/26/21 | 217.81 ₹ | -4.76% | 3,30,671 |
| 20/26/20 | 228.70 ₹ | -6.26% | 1,95,813 |
| 19/26/19 | 243.97 ₹ | -3.98% | 1,31,479 |
Delayed Quote NSE India S.E., January 23, 2026 at 03:58 pm IST
More quotes
Annual profits - Rate of surprise
- Stock Market
- Equities
- DCAL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition